NCT05349513 Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders
| NCT ID | NCT05349513 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Henri Laborit |
| Condition | Patients With Schizophrenia-like Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2022-02-23 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2022-02-23 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study use a new ecological questionnaire called ESSME developed by a care team in order to evaluate ecological environment of patients with schizophrenia-like disorders. Indeed, evaluation in an ecological environment would make it possible to be as close as possible to the concerns of theses patients, which could improve the care of this population, by making it possible to set with the patient objectives anchored in their daily life.
Eligibility Criteria
Inclusion Criteria: * man or woman aged 18 to 65 inclusive; * diagnosis of schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders version number 5 (DSM-V) criteria; * patient receiving care in a Center for Rehabilitation and Intersectoral Therapeutic Activities (CREATIV); * person who consented to the study; * affiliate or beneficiary of a social security scheme. Exclusion Criteria: * patient aged under 18 or over 65; * pregnant or breastfeeding women; * person unable or unwilling to receive a home visit; * person not consenting to the study; * presence of a diagnosis of an associated neurodevelopmental disorder; * presence of a diagnosis of dementia or associated neurodegenerative process; * person with a level of French language insufficient to understand the items.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05349513 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Patients With Schizophrenia-like Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05349513 currently recruiting?
Yes, NCT05349513 is actively recruiting participants. Contact the research team at carole.wangermez@ch-poitiers.fr for enrollment information.
Where is the NCT05349513 trial being conducted?
This trial is being conducted at Poitiers, France.
Who is sponsoring the NCT05349513 clinical trial?
NCT05349513 is sponsored by Centre Hospitalier Henri Laborit. The trial plans to enroll 56 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.